Literature DB >> 6143675

Evidence that apomorphine and pergolide induce rotation in rats by different actions on D1 and D2 receptor sites.

M Herrera-Marschitz, U Ungerstedt.   

Abstract

Apomorphine and the ergot derivative pergolide induced dose-dependent contralateral rotation in rats with unilateral 6-hydroxydopamine denervation of the ascending dopamine pathways. This was interpreted as an action on supersensitive receptors. However, large differences were found when comparing apomorphine and pergolide dose-response curves as well as the patterns of rotational behaviour the compounds elicited. Pergolide had a steep dose-response curve, while apomorphine had a flatter curve reaching a plateau at the dose of 1 mg/kg s.c. In doses higher than 1 mg/kg, apomorphine induced self-mutilation, while this was infrequent after pergolide. Apomorphine induced a two-peak pattern of rotation that never occurred when the same rats were tested with the ergot derivative. Both drugs induced dose-dependent ipsilateral rotation in animals with unilateral striatal kainic acid lesions but at doses 100 times higher. This effect was interpreted as an action on normosensitive receptors situated on the intact side. The differences between apomorphine and pergolide may be explained in terms of actions on different dopamine receptors, since the agonists were differently inhibited by neuroleptics acting on D1- or D2-type receptors. The D1/D2 antagonist cis-flupenthixol blocked both apomorphine and pergolide with similar potency, while sulpiride, a substituted benzamide devoid of any effect on D1 receptors, was a poor inhibitor of the apomorphine response. In contrast, sulpiride blocked pergolide rotation at doses 1000 times lower than those needed to block apomorphine rotation. Our results suggest the existence of functionally distinct sites related to the D1/D2 receptor classification.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6143675     DOI: 10.1016/0014-2999(84)90587-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  26 in total

1.  Neurotoxicological and neuroprotective elements in Parkinson's disease.

Authors:  Richard M. Kostrzewa; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2002-03       Impact factor: 3.911

2.  Regulatory aspects of nigrostriatal dopaminergic neurons.

Authors:  P Miu; F Karoum; G Toffano; J W Commissiong
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

3.  Vulnerability to a Metabolic Challenge Following Perinatal Asphyxia Evaluated by Organotypic Cultures: Neonatal Nicotinamide Treatment.

Authors:  R Perez-Lobos; C Lespay-Rebolledo; A Tapia-Bustos; E Palacios; V Vío; D Bustamante; P Morales; M Herrera-Marschitz
Journal:  Neurotox Res       Date:  2017-06-19       Impact factor: 3.911

4.  Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies.

Authors:  I Christensson-Nylander; M Herrera-Marschitz; W Staines; T Hökfelt; L Terenius; U Ungerstedt; C Cuello; W H Oertel; M Goldstein
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

5.  Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis.

Authors:  M Herrera-Marschitz; I Christensson-Nylander; T Sharp; W Staines; M Reid; T Hökfelt; L Terenius; U Ungerstedt
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

6.  Chronic implants of chromaffin tissue into the dopamine-denervated striatum. Effects of NGF on graft survival, fiber growth and rotational behavior.

Authors:  I Strömberg; M Herrera-Marschitz; U Ungerstedt; T Ebendal; L Olson
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

7.  Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats.

Authors:  J Arnt; J Hyttel
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

8.  Unilateral neonatal intracerebroventricular 6-hydroxydopamine administration in rats: I. Effects on spontaneous and drug-induced rotational behaviour and on postmortem monoamine levels.

Authors:  J Luthman; M Herrera-Marschitz; E Lindqvist
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

9.  Dopamine D2 blocking activity and plasma concentrations of remoxipride and its main metabolites in the rat.

Authors:  S O Ogren; J Lundström; L B Nilsson; M Widman
Journal:  J Neural Transm Gen Sect       Date:  1993

10.  On the mode of action of six putative dopamine receptor agonists on suppression of exploratory behaviour in rats.

Authors:  L Ståhle; U Ungerstedt
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.